4//SEC Filing
Curran Terrie 4
Accession 0000950170-24-084179
CIK 0001783183other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 2:50 PM ET
Size
5.6 KB
Accession
0000950170-24-084179
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Sale
Common Stock
2024-07-15$11.72/sh−33,848$396,699→ 377,734 total
Holdings
- 3,840.16(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]Includes 798 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001690298
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 2:50 PM ET
- Size
- 5.6 KB